Source: International Congress 2019 – From tobacco-related comorbidities to tobacco cessation



Rating:

Share or cite this content

Citations should be made in the following way:
A. Sánchez Azofra (Madrid, Spain), L. Diab Cáceres (Madrid, Spain), P. Landete Rodriguez (Madrid, Spain), C. Acosta Gutierrez (Madrid, Spain), B. Aldave Orzaiz (Madrid, Spain), E. Zamora García (Madrid, Spain), Á. González Rodríguez (Madrid, Spain), A. Martínez Vergara (Madrid, Spain), M. Churruca Arrospide (Madrid, Spain), J. Soriano (Madrid, Spain), J. Ancochea (Madrid, Spain). Applicability of vascular ultrasound in smoking patients.. 4483

Member's Comments

No comment yet.

Related content which might interest you: Duplex scanning of cerebral vessels in patients with chronic smoking Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease Year: 2013 Cerebral vascular reactivity in duplex scanning in patients with COPD Source: Annual Congress 2013 –COPD and tobacco management Year: 2013 Early detection of COPD is important for lung cancer surveillance Source: Eur Respir J 2012; 39: 1230-1240 Year: 2012 Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Computed tomography lung parenchymal descriptions in routine radiological reporting have diagnostic and prognostic utility in patients with idiopathic pulmonary arterial hypertension and pulmonary hypertension associated with lung disease Source: ERJ Open Res, 8 (1) 00549-2021; 10.1183/23120541.00549-2021 Year: 2022 Risk assessment in scleroderma patients with newly diagnosed pulmonary arterial hypertension: application of the ESC/ERS risk prediction model Source: Eur Respir J, 52 (4) 1800497; 10.1183/13993003.00497-2018 Year: 2018 Subclinical cardiovascular changes in chronic obstructive pulmonary disease patients: Doppler ultrasound evaluation Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 CT-scan identified pulmonary changes with smoking and aging in a healthy population Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases Year: 2014 Impact of the state of endothelium on clinical and functional parameters in COPD patients with arterial hypertension. Source: International Congress 2017 – Novel mechanisms and treatments for COPD Year: 2017 The clinical role of routine non-invasive parameters in the diagnostic work-up of patients with risk for pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models Year: 2012 Effect of smoking cessation on CT imaging in patients with COPD: a systematic review Source: Virtual Congress 2020 – Unusual tools for evaluating obstructive diseases Year: 2020 The sensitivity of D-dimer testing versus multislice CT in the diagnosis of postpartum pulmonary embolism in symptomatic high risk women Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011 Semiology of thoracic ultrasound (US) examination in lung transplant patients out of pulmonary complication. Source: International Congress 2017 – Lung transplant outcomes Year: 2017 Identification of patients with systemic sclerosis at high risk of pulmonary arterial hypertension using CT scanning techniques Source: Eur Respir J 2003; 22: Suppl. 45, 582s Year: 2003 Chartis evaluation of collateral ventilation versus HRCT assessment, in predicting clinical outcomes following endobronchial valve therapy (EBV) in COPD patients Source: Annual Congress 2012 - Endoscopic lung volume reduction: the growing evidence Year: 2012 Early radiologic diagnose and assessment of lung parenchyma in patients with mild COPD and constant progressive smoking Source: Annual Congress 2007 - Imaging modalities in asthma, COPD and emphysema Year: 2007 A fully automated cardiac magnetic resonance (CMR) assessment improves the evaluation of patients with pulmonary arterial hypertension (PAH) Source: Virtual Congress 2021 – Novel imaging analysis methodologies in diffuse lung diseases Year: 2021 Pulmonary hypertension is a common complication of COPD, but CT scanning and lung function tests do not identify patients at risk Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010 The impact of a lung cancer computed tomography screening result on smoking abstinence Source: Eur Respir J 2011; 37: 1466-1473 Year: 2011 Screening for pulmonary vascular disease (PVD) in patients with portal hypertension by investigating pulmonary hemodynamics during exercise Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension Year: 2017